Application 200795
- Type
- NDA
- Sponsor
- HOSPIRA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | INJECTABLE;INJECTION | 200MG/5.26ML (38MG/ML) | Yes | Yes |
| 002 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1GM/26.3ML (38MG/ML) | Yes | Yes |
| 003 | GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | INJECTABLE;INJECTION | 2GM/52.6ML (38MG/ML) | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0181 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0182 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
| 0409-0183 | Gemcitabine | GEMCITABINE | Hospira, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78619 | SUPPL | 2024-06-04 |
| 78612 | SUPPL | 2024-06-03 |
| 59178 | SUPPL | 2019-06-27 |
| 59161 | SUPPL | 2019-06-24 |
| 52621 | SUPPL | 2018-02-14 |
| 52134 | SUPPL | 2018-01-30 |
| 32062 | SUPPL | 2014-05-12 |
| 18980 | SUPPL | 2014-05-12 |
| 32061 | SUPPL | 2013-09-10 |
| 40046 | SUPPL | 2013-09-09 |
| 43356 | ORIG | 2012-07-06 |
| 24388 | ORIG | 2012-07-06 |
| 32060 | ORIG | 2011-08-08 |
| 40045 | ORIG | 2011-08-05 |